Kyverna Therapeutics, Inc.

10.47 USD
-0.03 (-0.29%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Kyverna Therapeutics, Inc. stock is up 40.73% since 30 days ago. The next earnings date is Aug 12, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 100% of the previous 1 July’s closed higher than June. 0% of analysts rate it a buy.

About Kyverna Therapeutics, Inc.

We are a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. We were incorporated in Delaware in June 2018 under the name BAIT Therapeutics, Inc., and changed our name to Kyverna Therapeutics, Inc. in October 2019. Our principal executive offices are located at 5980 Horton St., STE 550, Emeryville, CA.